GM2 gangliosidosis, unspecified
Billable / specific
E75.00 is a billable, specific ICD-10-CM code that can be used to indicate a diagnosis for reimbursement purposes in FY2027.
Inclusion terms
Includes (from E75)
- Note: All neoplasms, whether functionally active or not, are classified in Chapter 2. Appropriate codes in this chapter (i.e. E05.8, E07.0, E16-E31, E34.-) may be used as additional codes to indicate either functional activity by neoplasms and ectopic endocrine tissue or hyperfunction and hypofunction of endocrine glands associated with neoplasms and other conditions classified elsewhere.
Excludes1
Not coded here — never report together with this code.
- transitory endocrine and metabolic disorders specific to newborn (P70-P74) (from E75)
- androgen insensitivity syndrome (E34.5-) (from E75)
- congenital adrenal hyperplasia (E25.0) (from E75)
- hemolytic anemias attributable to enzyme disorders (D55.-) (from E75)
- Marfan syndrome (Q87.4-) (from E75)
- 5-alpha-reductase deficiency (E29.1) (from E75)
- mucolipidosis, types I-III (E77.0-E77.1) (from E75)
- Refsum's disease (G60.1) (from E75)
Excludes2
Not included here — may be reported together when both conditions exist.
Also known as
- Gangliosidosis, GM2
Parent code
- E75.0GM2 gangliosidosisHeader